Common Stock, Shares Authorized |
2B |
shares |
0% |
Q2 2025 |
FY 2025 |
Common Stock, Shares, Issued |
668M |
shares |
+2.72% |
Q2 2025 |
FY 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.28B |
USD |
+47.3% |
Q2 2025 |
FY 2025 |
Deferred Tax Assets, Valuation Allowance |
278M |
USD |
+14.3% |
Q2 2025 |
FY 2025 |
Deferred Tax Assets, Gross |
4.93B |
USD |
+13.5% |
Q2 2025 |
FY 2025 |
Operating Lease, Liability |
417M |
USD |
-6.5% |
Q2 2025 |
FY 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
1.18B |
USD |
-54.8% |
Q2 2025 |
FY 2025 |
Lessee, Operating Lease, Liability, to be Paid |
494M |
USD |
-8.33% |
Q2 2025 |
FY 2025 |
Property, Plant and Equipment, Gross |
1.03B |
USD |
+11.5% |
Q2 2025 |
FY 2025 |
Operating Lease, Liability, Current |
79.2M |
USD |
+20.2% |
Q2 2025 |
FY 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
95M |
USD |
+3.37% |
Q2 2025 |
FY 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
99.4M |
USD |
+17.2% |
Q2 2025 |
FY 2025 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q2 2025 |
FY 2025 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
76.5M |
USD |
-17.2% |
Q2 2025 |
FY 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Three |
94.3M |
USD |
+7.16% |
Q2 2025 |
FY 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
620M |
USD |
+5.95% |
Q2 2025 |
FY 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
FY 2025 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2025 |
FY 2025 |
Unrecognized Tax Benefits |
572M |
USD |
+25.9% |
Q2 2025 |
FY 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Four |
47.7M |
USD |
-45.5% |
Q2 2025 |
FY 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
FY 2025 |
Amortization of Intangible Assets |
166M |
USD |
+37.6% |
Q2 2025 |
FY 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
4.65B |
USD |
+13.5% |
Q2 2025 |
FY 2025 |
Share-based Payment Arrangement, Expense |
1.3B |
USD |
+20.5% |
Q2 2025 |
FY 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |